BioPharma Credit PLC (BOPCF)

BioPharma Credit Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.62	135.05	120.53	94.71	193.27
Cash & Short-Term Investments	5.62	135.05	120.53	94.71	193.27
Cash Growth	-95.84%	12.05%	27.26%	-51.00%	-34.85%
Accounts Receivable	31.71	20.23	19.73	9.59	0
Other Receivables	0.08	0.09	0.11	0.42	0.21
Receivables	31.8	20.32	19.84	10.01	0.21
Total Current Assets	37.42	155.37	140.37	104.72	193.48
Long-Term Investments	1,162	1,201	1,224	1,266	1,195
Total Assets	1,200	1,357	1,364	1,371	1,388
Accrued Expenses	16.94	15.87	24.35	6.34	9.39
Other Current Liabilities	0.95	-	1.95	-	-
Total Current Liabilities	17.88	15.87	26.3	6.34	9.39
Long-Term Unearned Revenue	0.06	-	0.26	0.56	-
Total Liabilities	17.94	15.87	26.56	6.9	9.39
Common Stock	13.74	13.74	13.74	13.74	13.74
Additional Paid-In Capital	607.13	607.13	607.13	607.13	607.13
Retained Earnings	560.81	720	716.59	742.85	758.05
Shareholders' Equity	1,182	1,341	1,337	1,364	1,379
Total Liabilities & Equity	1,200	1,357	1,364	1,371	1,388
Net Cash (Debt)	5.62	135.05	120.53	94.71	193.27
Net Cash Growth	-95.84%	12.05%	27.26%	-51.00%	-34.85%
Net Cash Per Share	0.00	0.10	0.09	0.07	0.14
Filing Date Shares Outstanding	1,140	1,254	1,319	1,374	1,374
Total Common Shares Outstanding	1,186	1,303	1,319	1,374	1,374
Working Capital	19.53	139.5	114.06	98.38	184.08
Book Value Per Share	1.00	1.03	1.01	0.99	1.00
Tangible Book Value	1,182	1,341	1,337	1,364	1,379
Tangible Book Value Per Share	1.00	1.03	1.01	0.99	1.00

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.